Literature DB >> 23588301

The Pharmacogenomics Research Network Translational Pharmacogenetics Program: overcoming challenges of real-world implementation.

A R Shuldiner1, M V Relling, J F Peterson, J K Hicks, R R Freimuth, W Sadee, N L Pereira, D M Roden, J A Johnson, T E Klein, Alan R Shuldiner, Mark Vesely, Shawn W Robinson, Nicholas Ambulos, Sanford A Stass, Mark D Kelemen, Lawrence A Brown, Toni I Pollin, Amber L Beitelshees, Richard Y Zhao, Ruth E Pakyz, Kathleen Palmer, Tameka Alestock, Courtney O'Neill, Kristin Maloney, Amie Branham, Danielle Sewell, Mary V Relling, Kristine Crews, James Hoffman, Shane Cross, Cyrine Haidar, Don Baker, J Kevin Hicks, Gillian Bell, Fran Greeson, Aditya Gaur, Ulrike Reiss, Alicia Huettel, Cheng Cheng, Amar Gajjar, Alberto Pappo, Scott Howard, Melissa Hudson, Ching-Hon Pui, Sima Jeha, William E Evans, Ulrich Broeckel, Russ B Altman, Li Gong, Michelle Whirl-Carrillo, Teri E Klein, Wolfgang Sadee, Kandamurugu Manickam, Kevin M Sweet, Peter J Embi, Dan Roden, Josh Peterson, Josh Denny, Jonathan Schildcrout, Erica Bowton, Jill Pulley, Marc Beller, Jennifer Mitchell, Ioana Danciu, Lisa Price, Naveen L Pereira, Richard Weinshilboum, Liewei Wang, Julie A Johnson, David Nelson, Michael Clare-Salzler, Amanda Elsey, Benjamin Burkley, Taimour Langaee, Felix Liu, David Nessl, Hui-Jia Dong, Larry Lesko, Robert R Freimuth, Christopher G Chute.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23588301      PMCID： PMC3720847          DOI： 10.1038/clpt.2013.59

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  4 in total

1.  CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network.

Authors:  M V Relling; T E Klein
Journal:  Clin Pharmacol Ther       Date:  2011-01-26       Impact factor: 6.875

Review 2.  Strategies for personalized medicine-based research and implementation in the clinical workflow.

Authors:  W Lieb; H Völzke; J M Pulley; D M Roden; H K Kroemer
Journal:  Clin Pharmacol Ther       Date:  2012-08-22       Impact factor: 6.875

Review 3.  Implementing personalized medicine: development of a cost-effective customized pharmacogenetics genotyping array.

Authors:  J A Johnson; B M Burkley; T Y Langaee; M J Clare-Salzler; T E Klein; R B Altman
Journal:  Clin Pharmacol Ther       Date:  2012-08-22       Impact factor: 6.875

4.  Pharmacogenomics and individualized medicine: translating science into practice.

Authors:  K R Crews; J K Hicks; C-H Pui; M V Relling; W E Evans
Journal:  Clin Pharmacol Ther       Date:  2012-09-05       Impact factor: 6.875
  4 in total
  82 in total

1.  A Template for Authoring and Adapting Genomic Medicine Content in the eMERGE Infobutton Project.

Authors:  Casey L Overby; Luke V Rasmussen; Andrea Hartzler; John J Connolly; Josh F Peterson; RoseMary E Hedberg; Robert R Freimuth; Brian H Shirts; Joshua C Denny; Eric B Larson; Christopher G Chute; Gail P Jarvik; James D Ralston; Alan R Shuldiner; Justin Starren; Iftikhar J Kullo; Peter Tarczy-Hornoch; Marc S Williams
Journal:  AMIA Annu Symp Proc       Date:  2014-11-14

2.  The CYP2C19*17 variant is not independently associated with clopidogrel response.

Authors:  J P Lewis; S H Stephens; R B Horenstein; J R O'Connell; K Ryan; C J Peer; W D Figg; S D Spencer; M A Pacanowski; B D Mitchell; A R Shuldiner
Journal:  J Thromb Haemost       Date:  2013-09       Impact factor: 5.824

Review 3.  Molecular pathways and therapies in autosomal-dominant polycystic kidney disease.

Authors:  Takamitsu Saigusa; P Darwin Bell
Journal:  Physiology (Bethesda)       Date:  2015-05

4.  Evidence for Clinical Implementation of Pharmacogenomics in Cardiac Drugs.

Authors:  Amy L Kaufman; Jared Spitz; Michael Jacobs; Matthew Sorrentino; Shennin Yuen; Keith Danahey; Donald Saner; Teri E Klein; Russ B Altman; Mark J Ratain; Peter H O'Donnell
Journal:  Mayo Clin Proc       Date:  2015-06       Impact factor: 7.616

5.  Community pharmacists' attitudes towards clinical utility and ethical implications of pharmacogenetic testing.

Authors:  Sony Tuteja; Kevin Haynes; Cara Zayac; Jon E Sprague; Barbara Bernhardt; Reed Pyeritz
Journal:  Per Med       Date:  2013-11       Impact factor: 2.512

6.  Pharmacogenomics, a novel section in the European Journal of Human Genetics.

Authors:  Henk-Jan Guchelaar
Journal:  Eur J Hum Genet       Date:  2018-07-02       Impact factor: 4.246

Review 7.  Standardization can accelerate the adoption of pharmacogenomics: current status and the path forward.

Authors:  Kelly E Caudle; Nicholas J Keeling; Teri E Klein; Michelle Whirl-Carrillo; Victoria M Pratt; James M Hoffman
Journal:  Pharmacogenomics       Date:  2018-06-19       Impact factor: 2.533

Review 8.  The Outlier in All of Us: Why Implementing Pharmacogenomics Could Matter for Everyone.

Authors:  P H O'Donnell; K Danahey; M J Ratain
Journal:  Clin Pharmacol Ther       Date:  2016-02-15       Impact factor: 6.875

9.  Medical student preparedness for an era of personalized medicine: findings from one US medical school.

Authors:  Caroline Eden; Kipp W Johnson; Omri Gottesman; Erwin P Bottinger; Noura S Abul-Husn
Journal:  Per Med       Date:  2016-03       Impact factor: 2.512

10.  Merging Electronic Health Record Data and Genomics for Cardiovascular Research: A Science Advisory From the American Heart Association.

Authors:  Jennifer L Hall; John J Ryan; Bruce E Bray; Candice Brown; David Lanfear; L Kristin Newby; Mary V Relling; Neil J Risch; Dan M Roden; Stanley Y Shaw; James E Tcheng; Jessica Tenenbaum; Thomas N Wang; William S Weintraub
Journal:  Circ Cardiovasc Genet       Date:  2016-03-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.